Eurofins Scientific SE Stock Wiener Boerse
Stocks
ESF
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Tradegate
23:59:59 24/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 78.03 EUR | +1.42% |
|
+4.54% | +23.78% |
| Market Cap | 13.49B 15.34B 12.72B 11.6B 21.7B 1,472B 21.87B 153B 59.15B 749B 57.59B 56.34B 2,439B | P/E 2026 * |
25.9x | P/E 2027 * | 20.5x |
|---|---|---|---|---|---|
| Enterprise Value | 16.86B 19.17B 15.89B 14.5B 27.12B 1,840B 27.33B 191B 73.9B 936B 71.96B 70.4B 3,047B | EV / Sales 2026 * |
2.22x | EV / Sales 2027 * | 2.07x |
| Free-Float |
60.39% | Yield 2026 * |
1.03% | Yield 2027 * | 1.17% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ERF | Real-time | |
CBOE
| Real-time | ||
|
London S.E.
| 0MV5 | Delayed | |
|
Tradegate
| ESF0 | Real-time | |
|
Xetra
| ESF0 | Delayed | |
|
OTC Markets
| ERFSF | Delayed | |
|
Börse Stuttgart
| ESF0 | Delayed | |
|
CBOE
| 0MV5 | Real-time | |
|
Boerse Muenchen
| ESF0 | Real-time | |
|
Deutsche Boerse AG
| ESF0 | Delayed | |
|
Wiener Boerse
| ESF | End-of-day quote | |
|
Borsa Italiana
| 4ERF | End-of-day quote |
Last Transcript: Eurofins Scientific SE
| 1 day | +1.42% | ||
| 1 week | +4.54% | ||
| Current month | +6.45% | ||
| 1 month | +6.45% | ||
| 3 months | +18.11% | ||
| 6 months | +24.34% | ||
| Current year | +23.78% |
| 1 week | 76.94 |  | 79.42 |
| 1 month | 70.64 | | 79.42 |
| Current year | 57.18 | | 79.42 |
| 1 year | 57.02 | | 79.42 |
| 3 years | 44.67 | | 79.42 |
| 5 years | 44.67 | | 114.38 |
| 10 years | 44.67 | | 126.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 01/01/1987 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 01/01/2015 |
Christian Wurst
PRN | Corporate Officer/Principal | 54 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 01/01/1987 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 01/01/2015 |
Valérie Hanote
BRD | Director/Board Member | 60 | 01/01/1990 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.42% | +4.54% | - | - | 15.06B | |
| +1.46% | +5.87% | +5.75% | +33.71% | 47.56B | |
| +2.73% | +2.08% | +51.76% | +35.90% | 44.09B | |
| -1.36% | +1.82% | +9.11% | +89.04% | 41.5B | |
| +4.96% | +1.55% | +359.32% | +577.93% | 40.88B | |
| -0.62% | +0.11% | +1.12% | +46.02% | 29.67B | |
| +0.59% | +1.04% | +24.99% | +154.02% | 17.23B | |
| +2.05% | +4.04% | +24.47% | +41.67% | 15.06B | |
| +3.48% | -4.35% | - | - | 14.65B | |
| +7.00% | +2.05% | +3.50% | - | 13.82B | |
| Average | +2.07% | +0.69% | +60.00% | +139.76% | 29.39B | |
| Weighted average by Cap. | +1.82% | +0.96% | +74.07% | +148.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.58B 8.62B 7.15B 6.52B 12.2B 828B 12.29B 85.79B 33.24B 421B 32.37B 31.67B 1,371B | 8B 9.09B 7.54B 6.88B 12.86B 873B 12.96B 90.47B 35.06B 444B 34.14B 33.4B 1,446B |
| Net income | 531M 604M 500M 457M 854M 57.94B 861M 6.01B 2.33B 29.49B 2.27B 2.22B 95.96B | 660M 750M 622M 567M 1.06B 71.99B 1.07B 7.46B 2.89B 36.64B 2.82B 2.75B 119B |
| Net Debt | 3.37B 3.83B 3.17B 2.89B 5.41B 367B 5.46B 38.08B 14.76B 187B 14.37B 14.06B 608B | 3.03B 3.45B 2.86B 2.61B 4.88B 331B 4.92B 34.32B 13.3B 168B 12.95B 12.67B 548B |
| Date | Price | Change |
|---|---|---|
| 23/09/26 | €76.94 | -3.12% |
| 24/09/26 | €78.30 | +1.77% |
| 23/09/26 | €76.94 | -3.12% |
| 22/09/26 | €79.42 | +2.21% |
| 21/09/26 | €77.70 | +0.34% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
- ESF Stock
Select your edition
All financial news and data tailored to specific country editions
